CD8A and neoplasm: Compared to the anti‐PD‐1 and F127ZIF‐8AB680 treatment alone, their combination demonstrated the highest degree of reversing the dysfunctional DCs and recruitment of the effector CD8+ T cells as shown by the flow cytometry and mIF staining (Figure 8h–l and Figure S18, Supporting Information), which was well consistent with the tumor response results.